Available: 07/01/2023 - 07/01/2026
Pricing
This course is free to members for the month of July. On August 1, 2023, the course will be available for purchase.
The goal of this session is to present the busy practitioner with a concise review of GAD, panic disorder, and SAD. The presentation will breifly discuss changes in our nosology as we move from DSM 5 to DSM 5TR and any implications this may have for diagnosis of these syndromes. Next, we will discuss an approach to conceptualizing how the social determinants of health and mental health may impact the pathogensis, recognition and treatment of anxiety disorders. The next portion of the presentation will focus on treatment options for patients with anxiety disorders. We will briefly discuss evidence-based psychotherapies and complementary and alternative treatment options but we will focus mainly on exisiting pharmacological treatment approaches for patients with anxiety disorders. We will discuss the value of both FDA-approved and non-FDA approved pharmacological strategies that can be employed depending on the severity and degress of treatment non-response encountered. The final component of this lecutre will explore how new technologies may play a disruptive influence on how we recognize people at risk for developing these syndromes, lead to preventative if not pre-emptive interventions, and may extend our treatment options.
Recorded webinar, non-interactive, self-paced distance learning activity.
This presentation was recorded at the American Psychiatric Association Annual Meeting 2022.
Psychiatrists
Estimated Duration: 90 minutesBegin Date: July 1, 2023End Date: July 1, 2026
Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the event date and hours earned.
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The APA designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Program Presenters
Program Planners
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of APA’s online resources, please contact us at 202-559-3900 for assistance.
This internet-based CME activity is best experienced using any of the following:
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
Minimum Requirements:
For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance